Biotech Pre-Seed Investors & VC Firms
896 firms in this list, with a median first check of $270K. 229 of them lead rounds. Generated from verified public data and updated continuously.
Elmehøj Ventures
CopenhagenPre-Seed–Series A
1 person
ExSight Ventures
Pre-Seed–Series B
4 people
OCCIDENT
MunichPre-Seed–Series A
4 people
Prefix Capital
San FranciscoPre-Seed–Seed
4 people
Southern Angels
AdelaidePre-Seed–Seed$25K – $680K
7 people
BlueOcean Ventures
GenevaPre-Seed–Series A$270K – $1.4M
6 people
Iron Wolf Capital
VilniusPre-Seed–Series A$540K – $5.4M
Nucleus Adventure Capital
Pre-Seed–Series A
3 people
Thundermark Capital
San JuanPre-Seed–Series A
8 people
CWRU Technology Ventures
ClevelandPre-Seed–Seed$50K – $250K
1 person
Neo Kuma Ventures
LondonPre-Seed–Series A$195K – $1.3M
7 people
Sinai Capital Partners
Pre-Seed–Seed
3 people
Unfold Ventures
WrocławPre-Seed–Late Stage$110K – $1.1M
6 people
Wallonie Entreprendre
LiègePre-Seed–Late Stage
9 people
Tet Ventures
BerlinPre-Seed–Series A$50K – $250K
1 person
EGORA Ventures AG
MartinsriedPre-Seed–Series B$5.4M
7 people
VIVES Partners
WavrePre-Seed–Series B$108K – $7.6M
4 people
Crossbeam Venture Partners
New YorkPre-Seed–Late Stage$1M – $1.5M
3 people
Simsan Ventures
LondonPre-Seed–Series A
8 people
Virginia Venture Partners
RichmondPre-Seed–Series A$100K
8 people
Label Investments
PamplonaPre-Seed–Late Stage$1.1M – $33M
2 people
Fundamental Ventures
LakewayPre-Seed–Late Stage
1 person
Cancer Focus
HoustonPre-Seed–Series A
9 people
Rockies Venture Adviser, Llc
DenverPre-Seed–Series A$100K – $500K
6 people
Related lists
Pre-Seed Investors & VC Firms (5679)Biotech Investors & VC Firms (2107)Pre-Seed Investors & VC Firms in United States (2090)AI & Machine Learning Pre-Seed Investors & VC Firms (1855)Biotech Seed Investors & VC Firms (1754)Biotech Series A Investors & VC Firms (1596)SaaS Pre-Seed Investors & VC Firms (1575)Pre-Seed Investors & VC Firms in Global (1485)Fintech Pre-Seed Investors & VC Firms (1477)Healthtech Pre-Seed Investors & VC Firms (1328)
Data sourced from public filings and firms' own websites — see our methodology.













































